Bulletin du Cancer

Aims & Scope

Without doubt, the 'Bulletin du Cancer' is the French language publication of reference in the field of cancerology.

Official organ of the French Society of Cancer, this journal covers all the information available, whether in the form of original articles or review articles, but also clinical cases and letters to the editor, including various disciplines as onco-hematology, solids tumors, medical oncology, pharmacology, epidemiology, biology as well as fundamental research in cancerology.

The journal proposes a clinical and therapeutic approach of high scientific standard and regular updates in knowledge are thus made possible.

Articles can be submitted in French or English.

View Aims & Scope

---

Metrics & Ranking

Journal Rank

Year	Value
2024	15810

Journal Citation Indicator

Year	Value
2024	489

Impact Factor

Year	Value
2024	1.10

SJR (SCImago Journal Rank)

Year	Value
2024	0.327

Quartile

Year	Value
2024	Q3

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• An overview of autophagy: Mechanism, regulation and research progress

  Citation: 324

  Authors: Weiya, Jinhong, Kepeng, Dongli

• A review on hyperthermia via nanoparticle-mediated therapy

  Citation: 101

  Authors: Ayesha, Zaki, O. Anwar, Sarmad, Lubna

• Ateliers d’harmonisation des pratiques de la SFGM-TC

  Citation: 100

  Authors: Rachel, Ibrahim

• Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1

  Citation: 98

  Authors: Qian, Anding, Li

• Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx

  Citation: 92

  Authors: Marie-Anne, Joseph, Fabienne, Chantal, Bernard, Gérard, Nicolas, Laurent, Céline, Céline, Antonin, Christine, Alexandre, Angelo, Vianney, Sylvie, Alexandre, Benjamin, Franck, Xavier, Claire, Anne-Sophie, Fadil, Jean-Christophe, Marie-Christine

• Colorectal cancer cell–derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway

  Citation: 89

  Authors: Guangyao, Xiaoguang, Yubin, Jianbin, Yunfeng, Fei, Jingcheng

• MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors

  Citation: 79

  Authors: Magali, Olivier, Romain, Ada, Vincent, Jean-François, Olivier, Alex

• Épidémiologie descriptive des cancers en France métropolitaine : incidence, survie et prévalence

  Citation: 73

  Authors: Anne, Marc, Karine, Valérie, Gautier, Alain, Brice, Patrick, Isabelle, Simona, Anne-Marie, Véronique, Jacqueline, Marc, Gaëlle, Anne, Tania, Laetitia, Gautier, Patricia, Jacqueline, Pascale, Anne-Valérie, Clarisse, Brigitte, Bénédicte, Emilie, Marc, Florence, Alain, Jean-Baptiste, Juliette, Sandrine, Camille, Michel, Claire, Brigitte, Xavier, Michel, Anne-Sophie

• Immunotherapy and patients treated for cancer with microsatellite instability

  Citation: 68

  Authors: Raphaël, Romain, Delphine, Alex, Olivier, Daniel, Pauline, Isabelle, Yann, Jérémie H., Jean-François, Magali, Thierry

• Long non-coding RNA H19 and cancer: A competing endogenous RNA

  Citation: 65

  Authors: Yafen, Ao, Anwen

---